A Non-interventional Prospective Study of Early HER2-negative High-risk Breast Cancer and BRCA1/2 Mutations Prevalence in RussiA
Clinical trial NCT05939128 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05939128
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-06-30
- Primary completion
- 2027-09-30
- Enrollment
- 625
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.